Stefany Shaheen: It's time to channel our outrage into action
Our family was forever changed when our daughter, Elle, was diagnosed with Type 1 diabetes shortly after her eighth birthday. It was Thanksgiving, and I can still see the room we were in at Boston's Children's Hospital. I vividly remember sitting on an old radiator under a tall window in the middle of the night as Elle slept attached to machines and too many tubes. That night, I felt the despair shared by any parent who is powerless to prevent their child's suffering. And every night since, for the last 17 years, I have worried about our daughter's health and safety.
A century ago, Type 1 diabetes would have been a death sentence. Today, this is a disease Elle and more than one million other Americans can live with because of discoveries made possible, in part, through publicly-funded research. The United States has always been the place where innovation and science lead the way to life-changing discoveries and medical advancements. In fact, investments in medical research are responsible for recent breakthroughs in cancer treatments, diabetes care, and numerous other chronic conditions.
Now, Donald Trump, Elon Musk, and Robert F. Kennedy Jr. are making devastating cuts to medical research and jeopardizing the progress being made to find new treatments and ultimately cure numerous diseases. From cancer research to vaccinations, they are carelessly ending promising clinical trials and endangering public health while throwing away some of the best doctors and scientists in our country to give tax cuts to billionaires. By eliminating the possibility for better treatments and cures, the Trump administration threatens America's standing as the world leader in global innovation as they steal our hope. I refuse to stand by and watch while they risk the safety of our children and destroy the promise of better days ahead for our families.
Musk, Trump and Kennedy Jr., are taking their chainsaw to healthcare for everyone. Community health centers, which, here in New Hampshire, serve more than 90,000 people — particularly children who have no other source of medical care are facing devastating cuts. More than 180,000 people in New Hampshire rely on Medicaid and the Children's Health Insurance Program.
Health care is already too expensive. If Trump succeeds in slashing Medicaid and imposing his across-the-board tariffs, it will be a financial one-two punch for working families. Annual medical costs for everyone will spike, straining already tight family budgets.
Cuts to organizations like the Centers for Disease Control and Prevention will impact all of us by leaving state and local health officials without critical information and guidance, on even the most basic health threats, like the flu, all while measles is surging. It is criminal that in the United States of America two children have already died from measles and there are more than 1,000 active cases in the country right now. This is a disease that we know how to prevent and we eradicated before, but it is back and threatens to take even more lives.
I could not prevent Elle's diagnosis, but inspired by her strength and determination, I have helped people with chronic conditions live safer and healthier lives. I started a small business to connect people with the support they need to feel better and meet their body's nutritional needs. This led me to work with doctors and researchers at hospitals and in labs across the country who have dedicated their lives to accelerating treatments for the most costly diseases.
Now, I'm part of an effort, in Manchester, New Hampshire, to deliver next generation therapies and even cures for some of the toughest health problems — from treating injured war fighters to diabetes, lung disease and many others. Not only is this the right thing to do, but the National Institutes of Health estimates that for every $1 invested in research, more than $2.50 in economic activity is generated. It's a win-win.
Living with constant threats to the health and safety of children is something that I will never accept, because it doesn't have to be this way. America leads the world in scientific discoveries for health care. The best treatments for everything exist here because most were developed here. We will not be able to recover what is being stolen from us right now. It is not enough to keep our heads down and try to work through this chaos, cruelty and corruption. There is simply too much at stake. No family will be left untouched. It is time to channel our outrage into action.
Stefany Shaheen lives in Portsmouth and is a former member of the City Council and Police Commission.
This article originally appeared on Portsmouth Herald: Stefany Shaheen: It's time to channel our outrage into action
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
25 minutes ago
- CNN
Trump lays into Musk, suggesting he has ‘Trump derangement syndrome'
President Donald Trump appeared to confirm the deterioration of his relationship with Elon Musk, saying he was 'very disappointed' in the tech billionaire after Musk repeatedly blasted the president's sweeping domestic agenda bill in recent days. 'Elon and I had a great relationship. I don't know if we will anymore,' Trump told reporters in the Oval Office less than one week after the two exchanged effusive praise on Musk's last day as a special government employee. Since then, Musk has strongly criticized what Trump calls his 'Big, Beautiful Bill' that has passed the House and faces an uncertain path forward in the Senate. On Tuesday, Musk called the bill a 'disgusting abomination.' Trump and Musk have not spoken since Musk lashed out at the legislation, a source familiar with the dynamic told CNN. 'He knew every aspect of this bill. He knew it better than almost anybody, and he never had a problem until right after he left,' Trump said, adding that while Musk has not yet personally attacked him, the president expected that could be next. Trump repeatedly claimed that Musk's concerns with the bill were centered on the repeal of electric vehicle subsidies that benefitted Tesla. Musk has admitted his company has struggled in the wake of his political involvement. Musk didn't wait to respond, posting his reactions in real time on his social media platform X. 'Without me, Trump would have lost the election, Dems would control the House and the Republicans would be 51-49 in the Senate,' Musk said. He added: 'Such ingratitude.' Musk denied Trump's claim that the Tesla CEO knew the inner workings of the bill ahead of time, and countered that the elimination of EV tax incentives has nothing to do with his opposition to the massive domestic policy bill. 'Whatever. Keep the EV/solar incentive cuts in the bill, even though no oil & gas subsidies are touched (very unfair!!), but ditch the MOUNTAIN of DISGUSTING PORK in the bill' Musk in a separate post. 'In the entire history of civilization, there has never been legislation that both big and beautiful. Everyone knows this! Either you get a big and ugly bill or a slim and beautiful bill. Slim and beautiful is the way.' One Republican strategist who has worked closely with the tech billionaire downplayed the idea that Musk's opposition is only about the EV subsidies, telling CNN that Musk was genuinely troubled by projections of how much the bill would add to the deficit – the reasoning Musk has publicly cited on multiple occasions. The nonpartisan Congressional Budget Office has estimated that the legislation passed by the House would increase the deficit by $2.4 trillion. During Thursday's Oval Office appearance alongside German Chancellor Friedrich Merz, Trump reminisced about his campaign bromance with Musk, who contributed at least a quarter-billion dollars to efforts supporting Trump's 2024 presidential bid and once called himself Trump's 'first buddy.' 'Elon endorsed me very strongly. He actually went up and campaigned for me. I think I would have won – Susie would say I would have won Pennsylvania easily anyway,' Trump said, referring to his chief of staff Susie Wiles, appearing to hint at tensions between Wiles and Musk. Trump appeared to moderate his tone at times, saying he 'always liked Elon' – before implicitly accusing him of so-called 'Trump Derangement Syndrome.' 'He's not the first – people leave my administration, and they love us, and then at some point they miss it so badly, and some of them embrace it, and some of them actually become hostile. I don't know what it is. It's sort of 'Trump derangement syndrome,' I guess they call it, but we have it with others too,' he said. 'They leave, and they wake up in the morning, and the glamour is gone,' he continued. 'The whole world is different, and they become hostile. I don't know what it is.' Kristen Holmes contributed to this report.
Yahoo
26 minutes ago
- Yahoo
Delta warns new tariffs could force it to stop buying foreign-made airplanes
WASHINGTON (Reuters) -Delta Air Lines warned new tariffs on imported airplanes and parts could force the airline to stop buying foreign-made planes impacting millions of customers. The Atlanta-based carrier told the U.S. Commerce Department in comments seen by Reuters Thursday that in 2023 and 2024 it took delivery of 47 Airbus aircraft produced in Canada, Germany and France. If the carrier had not been able to take delivery of those planes because of tariffs it would have forced flight cancellations impacting 10 million customers. Delta said a "similar impact could be expected going forward" if the Trump administration imposes new tariffs.
Yahoo
26 minutes ago
- Yahoo
Why Tesla (TSLA) Shares Are Trading Lower Today
Shares of electric vehicle pioneer Tesla (NASDAQ:TSLA) fell 4.9% in the afternoon session as momentum slowed after a 40% rally that followed the Q1 2025 selloff, suggesting that the recent surge may have exhausted short-term buying interest. It is also possible some investors were taking profits amid uncertainty as they wait for more concrete updates on Tesla's highly anticipated product updates scheduled for later this year. These updates are critical for improving Tesla's growth story, as reported sales in Europe and China were weak in the first quarter of the year. Contributing to the pullback, a widely circulated Bloomberg report resurfaced concerns about the safety of Tesla's driver-assistance technology, highlighting a fatal 2023 crash. The timing of the story is especially sensitive, as Tesla prepares to unveil its AI-powered robo-taxi service in Austin later in the month, a launch that risked being overshadowed by renewed scrutiny and could shake investor confidence in the company's autonomous driving ambitions. Adding to the wall of worry is Elon Musk increasingly looking like an enemy to President Trump rather than a confidant. President Trump has shown the willingness to punish companies that do not fall in line with his agenda and vision. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Tesla? Access our full analysis report here, it's free. Tesla's shares are extremely volatile and have had 131 moves greater than 2.5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 9 days ago when the stock gained 5.2% after the major indices (Nasdaq +2.0%, S&P 500 +1.5%) rebounded as President Trump postponed the planned 50 % tariff on European Union imports, shifting the start date to July 9, 2025. Companies with substantial business ties to Europe likely had some relief as the delay reduced near-term cost pressures and preserved cross-border demand. The update should be beneficial for Tesla, as data from the European Automobile Manufacturers' Association revealed the company sold 7,261 cars in Europe in April, down 49% year on year. So, the delay could help the company avoid being caught in the crossfire of retaliatory tariffs and potential complications from escalating trade tensions between the US and the EU. Contributing to the stock's momentum, CEO Elon Musk noted in a social media post on X (formerly Twitter) that he would be allocating more of his time to the company. He added, "I must be super focused on /xAI and Tesla (plus Starship launch next week), as we have critical technologies rolling out." Tesla is down 19.8% since the beginning of the year, and at $304.24 per share, it is trading 36.6% below its 52-week high of $479.86 from December 2024. Investors who bought $1,000 worth of Tesla's shares 5 years ago would now be looking at an investment worth $5,152. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data